POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Scientists develop new form of antibiotic to combat multidrug resistant bacteria

Staff Writer |
A new antibiotic, developed by an Australian led-team of scientists, could present a solution to the problem of drug resistant bacteria, which is expected to present an ever increasing concern in the coming century.

Article continues below




The new kind of antibiotic was developed to limit multidrug resistance by targeting and disrupting key elements in bacterial cells, by scientists from Griffith University (GU), in collaboration with colleagues from Queensland University of Technology, the United States' Indiana University and China's Dezhou University.

"We tried to develop a new type of antibiotics that act differently than what we are using right now," Professor Yaoqi Zhou from GU's Institute for Glycomics told Xinhua.

"The way most antibiotics stop key functions in bacteria is that they bind to the surface of an essential protein so that it is unable to perform its normal function."

"Our technique with this new antibiotic approach is different - instead of binding to the surface of the protein, we disrupt the structure of the protein, which stops it functioning."

In one test Zhou said, the team saw a 500-fold resistance develop to a commonly used antibiotic over 30 days, where as their newly developed antibiotic encountered no developed resistance at all.

Additionally the new drug may be useful in cancer treatment, another area where drug resistance is a major hurdle.

"What we've found in the concept is that it's not only working for antibiotics but should also work for anti-cancer, which also has a lot of problems in terms of drug resistance, also anti-viral - viral infections have a lot of problems with anti-drug resistance," Zhou said.

"So I think this is a concept that should be useful for any other kinds of disease which also has problems with drug resistance issues."

Although still in the early theoretical stage, Zhou is hopeful that the method will progress to animal testing and eventually clinical trials, and provide an answer to what is an increasingly urgent international crisis.


What to read next

Multidrug resistant bacteria found in hospital sinks
WHO publishes list of bacteria for which new antibiotics are urgently needed
Cutting-edge technology sheds light on antibiotic resistance